About Daniel Galles
Form D filings for RxRevu from 2021 to 2023 list Daniel Galles as director.
Daniel Galles first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Daniel Galles in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Daniel Galles works with at each company, as listed on that company's latest Form D.
RxRevu, Inc. · Form D, Jan 17, 2023
SM
Stephen McHale
Director
KK
Kyle Kiser
Chief Executive Officer and director
AF
Andrew Firlik
Director
SL
Steve Lindseth
Executive officer and director
CC
Christie Callahan
Executive officer
TC
Toby Cosgrove
Director
AP
Albert Prast
Director
BB
Benton Barney
Executive officer
RZ
Richard Zane
Director
AC
Aaron Cornell
Executive officer
LP
Lew Parker
Executive officer